Bacteroides coprosuis

Bacteria
General | Carbohydrate O/F | Substrate utilisation | Enzymes | Metabolites | Antibiotics

Overview

  • Bacteroides coprosuis is a Gram-negative, non-spore-forming, anaerobic, non-motile, rod-shaped bacterium. It has been detected in at least 3 gut microbiome compilation studies or metastudies. The DNA G+C content is 35.0-36.4%. Bacteroides coprosuis is probably a rare gut coloniser. (Whitehead2005)



  • This organism has been recovered from pig faeces. The risk classification (www.baua.de) for this organism is 1, i.e., low risk of infection and spread. Pathogenicity status unknown, or very unlikely to be pathogenic. A possible gut commensal.
    • GENERAL CHARACTERISTICS (Whitehead2005);
    Character Response
  • Substrates hydrolysed or digested:
  • aesculin; starch;
  • 🌡
  • Temperature tolerance:
  • Grows optimally at 37℃.
  • ⥅
  • Substrates assimilated or utilised:
  • glucose; maltose; H2 consumed; CO2 consumed;
  • Active enzymes:
  • Ala arylamidase; alkaline phosphatase; acid phosphatase; Arg arylamidase; N-Ac β-glucosaminidase; chymotrypsin; cystine arylamidase; esterase C4; esterase lipase C8; β-galactosidase; α-glucosidase; β-glucosidase; Glu-Glu arylamidase; Leu-Gly arylamidase; lipase C14;
    • SPECIAL FEATURES (Whitehead2005);
    Character Response
  • ✓
  • Metabolites produced:
  • acetate; propionate; succinate;
  • ✗
  • Metabolites not produced:
  • indole;
  • ✗
  • Nitrate:
  • not reduced
    • RESPONSE TO ANTIBIOTICS (Whitehead2005);
    Class Active Resistant
  • Penicillins:
  • amoxicillin;
  • Cephalosporins:
  • cefoxitin;
  • Macrolides:
  • erythromycin;
  • Tetracyclines:
  • tetracycline;
  • Aminoglycosides:
  • gentamicin;

    • Details

    GENERAL
    Lineage Physiology General Growth Tolerances Hydrol./digest./degr.
    Phylum:  Bacteroidetes Class:  Bacteroidia Order:  Bacteroidales Family:  Bacteroidaceae Genus:  Bacteroides Gram stain:  neg O2 Relation.:  anaerobic Spore:  No spore Motility:  Sessile Morphology:  Rod
    Health:  Unknown
    Source:  pig faeces
    DNA G+C(%):  35.0-36.4
    Opt. T:  37℃
    		Aesculin:  + Gelatin:  neg Starch:  +
    CARBOHYDRATE ACID FORMATION
    Monosaccharide O/F Oligosaccharide O/F Polysaccharide O/F Polyol O/F Other O/F
    SUBSTRATE ASSIMILATION & UTILISATION
    Monosaccharide util/assim Oligosaccharide util/assim Other carboh. util/assim Amino acid util/assim Organic acid util/assim
    Glucose:  + Maltose:  +
    ENZYME ACTIVITY
    Enzymes: General Enzymes: Carbohydrate Enzymes: Protein Enzymes: Arylamidases Enzymes: Esters/fats
    Oxidase:  neg Catalase:  neg Urease:  neg α-Arab:  neg Ac-β-glcamnd:  + α-Fucosidase:  neg β-Galactosidase:  + α-Glucosidase:  + β-Glucosidase:  + β-Glucuronidase:  neg α-Mannosidase:  neg ArgDH:  neg Chymotrypsin:  + Trypsin:  neg AlanineAA:  + ArgAA:  + CystineAA:  + GluGluAA:  + GlyAA:  neg HisAA:  neg LeuAA:  neg LeuGlyAA:  + ProAA:  neg PyrogluAA:  neg SerAA:  neg TyrAA:  neg ValAA:  neg AlkalineP:  + AcidP:  + Esterase(C4):  + EstLip(C8):  + Lipase(C14):  + Phosphoamidase:  neg
    METABOLITES - PRODUCTION & USE
    Fuel Usable Metabolites Metabolites Released Special Products Compounds Produced

    		Acetate:  + Propionate:  + Succinate:  + Indole:  neg
    ANTIBIOTICS ℞
    Penicillins & Penems (μg/mL) Cephalosporins (μg/mL) Aminoglycosides (μg/mL) Macrolides (μg/mL) Quinolones (μg/mL)
    amoxicillin:  R(100; disc)
    cefoxitin:  R(20; disc)
    gentamicin:  R(200; disc)
    erythromycin:  R(10; disc)
    Tetracyclines (μg/mL) Vancomycin Class (μg/mL) Polypep/ketides (μg/mL) Heterocycles (μg/mL) Other (μg/mL)
    tetracycline:  R(3; disc)

    References

    SPECIFIC REFERENCES FOR BACTEROIDES COPROSUIS
  • Whitehead2005 - Bacteroides coprosuis sp. nov., isolated from swine-manure storage pits.
  • Hahnke2016a - Genome-Based Taxonomic Classification of Bacteroidetes.
  • ...............................
    • GUT MICROBIOME COMPILATIONS AND METASTUDIES FOR BACTEROIDES COPROSUIS
  • Byrd2020 - Stability and dynamics of the human gut microbiome and its association with systemic immune traits.
  • New2022 - Collective effects of human genomic variation on microbiome function.
  • Zeller2014 - Potential of fecal microbiota for early-stage detection of colorectal cancer
  • ...............................
    • Added: March 18, 2022